Cerus
CERS
#7694
Rank
S$0.46 B
Marketcap
S$2.43
Share price
-9.42%
Change (1 day)
1.35%
Change (1 year)

Cerus (CERS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.19 Billion

According to Cerus's latest financial reports the company's total liabilities are S$0.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cerus - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.19 B2.72%
2023-12-31S$0.19 B-4.93%
2022-12-31S$0.20 B-2.37%
2021-12-31S$0.20 B31.97%
2020-12-31S$0.15 B6.38%
2019-12-31S$0.14 B35.62%
2018-12-31S$0.10 B35.96%
2017-12-31S$79.31 M19.95%
2016-12-31S$66.12 M4.73%
2015-12-31S$63.14 M18.71%
2014-12-31S$53.19 M3.44%
2013-12-31S$51.42 M41.05%
2012-12-31S$36.45 M4.06%
2011-12-31S$35.03 M11.31%
2010-12-31S$31.47 M71.89%
2009-12-31S$18.31 M-1.97%
2008-12-31S$18.67 M-29.16%
2007-12-31S$26.36 M15.82%
2006-12-31S$22.76 M-41.53%
2005-12-31S$38.93 M-70.38%
2004-12-31S$0.13 B17.36%
2003-12-31S$0.11 B284.8%
2002-12-31S$29.11 M-26.87%
2001-12-31S$39.81 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Haemonetics
HAE
S$2.06 B 941.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$3.37 M-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
S$24.75 B 12,370.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
S$4.24 M-97.86%๐Ÿ‡บ๐Ÿ‡ธ USA